- 2 updates
The researchers say the approach defines a completely new concept in treating allergies and in the future could have an impact on treating other conditions such as asthma and food allergies.
Hayfever affects one in four people in the UK.
Tablets and sprays may temporarily relieve symptoms, but for severe cases one option is a vaccine to switch off the allergy, called immunotherapy.
The vaccines currently used involve high doses of allergen given by injection underneath the skin or as a daily tablet or drops.
In most cases this involves large numbers of injections in an NHS allergy clinic or daily tablets/drops taken continuously, which can be inconvenient for patients and expensive for the NHS.
It may be September and the threat of hayfever may be receding, but there is new hope for summers to come as researchers have found a new vaccine for hayfever which could be more effective, less invasive for patients and less expensive than vaccines already available to patients within the NHS.
Scientists at Imperial College London and Kings College London have carried out a study which was so successful they have launched a clinical trial in collaboration with Guys Hospital.